Yi-Pin Lin

Yi-Pin Lin

Auto-generated profile, based on publicly available information

Yi-Pin Lin

Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine, Tufts University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2020 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
YLYi-Pin Lin
Yi-Pin Lin
AFAmber M. Frye
Amber M. Frye
TNTristan A. Nowak
Tristan A. Nowak
PKPeter Kraiczy
Peter Kraiczy
Lyme disease (LD), which is caused by genospecies of the Borrelia burgdorferi sensu lato complex, is the most common vector-borne disease in the Northern hemisphere. Spirochetes are transmitted by Ixodes ticks and maintained in diverse vertebrate animal hosts. Following tick bite, spirochetes initially establish a localized infection in the skin. However, they may also disseminate hematogenously to several distal sites, including heart, joints, or the CNS. Because they need to survive in diverse microenvironments, from tick vector to mammalian hosts, spirochetes have developed multiple strategies to combat the numerous host defense mechanisms. One of these strategies includes the production of a number of complement-regulator acquiring surface proteins (CRASPs) which encompass CspA, CspZ, and OspE paralogs to blunt the complement pathway. These proteins are capable of preventing complement activation on the spirochete surface by binding to complement regulator Factor H. The genes encoding these CRASPs differ in their expression patterns during the tick-to-host infection cycle, implying that these proteins may exhibit different functions during infection. This review summarizes the recent published reports which investigated the roles that each of these molecules plays in conferring tick-borne transmission and dissemination in vertebrate hosts. These findings offer novel mechanistic insights into LD pathobiology and may facilitate the identification of new targets for preventive strategies against Lyme borreliosis.

29 May 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
THThomas Hart
Thomas Hart
NNNgoc Thien Thu Nguyen
Ngoc Thien Thu Nguyen
NNNancy A Nowak
Nancy A Nowak
FZFuming Zhang
Fuming Zhang
RLRobert Linhardt
Robert Linhardt
YLYi-Pin Lin
Yi-Pin Lin
Borrelia burgdorferi sensu lato (Bbsl), the causative agent of Lyme disease, establishes an initial infection in the host’s skin following a tick bite, and then disseminates to distant organs, leading to multisystem manifestations. Tick-to-vertebrate host transmission requires that Bbsl survives during blood feeding. Complement is an important innate host defense in blood and interstitial fluid. Bbsl produces a polymorphic surface protein, CspA, that binds to a complement regulator, Factor H (FH) to block complement activation in vitro. However, the role that CspA plays in the Bbsl enzootic cycle remains unclear. In this study, we demonstrated that different CspA variants promote spirochete binding to FH to inactivate complement and promote serum resistance in a host-specific manner. Utilizing a tick-to-mouse transmission model, we observed that a cspA-knockout B. burgdorferi is eliminated from nymphal ticks in the first 24 hours of feeding and is unable to be transmitted to naïve mice. Conversely, ectopically producing CspA derived from B. burgdorferi or B. afzelii, but not B. garinii in a cspA-knockout strain restored spirochete survival in fed nymphs and tick-to-mouse transmission. Furthermore, a CspA point mutant, CspA-L246D that was defective in FH-binding, failed to survive in fed nymphs and at the inoculation site or bloodstream in mice. We also allowed those spirochete-infected nymphs to feed on C3-/- mice that lacked functional complement. The cspA-knockout B. burgdorferi or this mutant strain complemented with cspA variants or cspA-L246D was found at similar levels as wild type B. burgdorferi in the fed nymphs and mouse tissues. These novel findings suggest that the FH-binding activity of CspA protects spirochetes from complement-mediated killing in fed nymphal ticks, which ultimately allows Bbsl transmission to mammalian hosts. Lyme disease, the most common vector-borne disease in the United States, is caused by the bacterium, Borrelia burgdorferi. This bacterium is transmitted to humans via the bite of a tick, and then spreads from the bite site to multiple tissues. Tick-to-human transmission of this bacterium requires bacterial survival in fed ticks because the blood and body fluid that ticks consume contain complement, an important mechanism that kills bacteria. To prevent host cell damage by this powerful mechanism, vertebrate animals produce factor H to inhibit complement. Lyme disease bacteria produce a surface protein CspA that binds to factor H to inhibit complement, but the role that CspA-mediated factor H-binding activity plays in tick-to-human transmission remains unexplained. To investigate this, we infected mice with Lyme disease strains that were identical except for the CspA variant or mutant with no factor H-binding ability they produced. We found that the factor H-binding activity of CspA appears to prevent the bacteria from being killed by complement in fed nymphal ticks. Such ability further facilitates bacterial transmission to mice. These results will promote the development of strategies against CspA to intervene in Lyme disease bacterial transmission from ticks to humans.

1 July 2020 in Trends in Parasitology
Verified
Journal Article
Closed access
YLYi-Pin Lin
Yi-Pin Lin
MDMaria A. Diuk-Wasser
Maria A. Diuk-Wasser
BSBrian Stevenson
Brian Stevenson
PKPeter Kraiczy
Peter Kraiczy

15 May 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
YLYi-Pin Lin
Yi-Pin Lin
XTXi Tan
Xi Tan
JCJennifer A. Caine
Jennifer A. Caine
MCMildred Castellanos
Mildred Castellanos
GCGeorge Chaconas
George Chaconas
JLJohn M. Leong
John M. Leong
Lyme disease, caused by Borrelia burgdorferi, B. afzelii and B. garinii, is a chronic, multi-systemic infection and the spectrum of tissues affected can vary with the Lyme disease strain. For example, whereas B. garinii infection is associated with neurologic manifestations, B. burgdorferi infection is associated with arthritis. The basis for tissue tropism is poorly understood, but has been long hypothesized to involve strain-specific interactions with host components in the target tissue. OspC (outer surface protein C) is a highly variable outer surface protein required for infectivity, and sequence differences in OspC are associated with variation in tissue invasiveness, but whether OspC directly influences tropism is unknown. We found that OspC binds to the extracellular matrix (ECM) components fibronectin and/or dermatan sulfate in an OspC variant-dependent manner. Murine infection by isogenic B. burgdorferi strains differing only in their ospC coding region revealed that two OspC variants capable of binding dermatan sulfate promoted colonization of all tissues tested, including joints. However, an isogenic strain producing OspC from B. garinii strain PBr, which binds fibronectin but not dermatan sulfate, colonized the skin, heart and bladder, but not joints. Moreover, a strain producing an OspC altered to recognize neither fibronectin nor dermatan sulfate displayed dramatically reduced levels of tissue colonization that were indistinguishable from a strain entirely deficient in OspC. Finally, intravital microscopy revealed that this OspC mutant, in contrast to a strain producing wild type OspC, was defective in promoting joint invasion by B. burgdorferi in living mice. We conclude that OspC functions as an ECM-binding adhesin that is required for joint invasion, and that variation in OspC sequence contributes to strain-specific differences in tissue tropism displayed among Lyme disease spirochetes. Infection by different Lyme disease bacteria is associated with different manifestations, such as cardiac, neurologic, or, in the case of B. burgdorferi, the major cause of Lyme disease in the U.S., joint disease. The basis for these differences is unknown, but likely involve strain-specific interactions with host components in the target tissue. The sequence of the outer surface lipoprotein OspC varies with the strains, and we found that this variation influences the spectrum of host extracellular matrix components recognized. Infection of mice with strains that are identical except for ospC revealed that OspC variants that differ in binding spectrum promote infection of different tissues. A strain producing OspC invaded and colonized the joint in living animals, but an altered OspC protein incapable of binding tissue components did not. Thus, tissue-binding by OspC is critical for infection and joint invasion, and OspC variation directly influences tissue tropism.

20 December 2018 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
AMAshley L. Marcinkiewicz
Ashley L. Marcinkiewicz
ADAlan P. Dupuis
Alan P. Dupuis
MZMaxime Zamba‐Campero
Maxime Zamba‐Campero
NNNancy Nowak
Nancy Nowak
PKPeter Kraiczy
Peter Kraiczy
YLYi‐Pin Lin
Yi‐Pin Lin
Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. The spirochetes are transmitted from mammalian and avian reservoir hosts to humans via ticks. Following tick bites, spirochetes colonize the host skin and then disseminate haematogenously to various organs, a process that requires this pathogen to evade host complement, an innate immune defence system. CspZ, a spirochete surface protein, facilitates resistance to complement-mediated killing in vitro by binding to the complement regulator, factor H (FH). Low expression levels of CspZ in spirochetes cultivated in vitro or during initiation of infection in vivo have been a major hurdle in delineating the role of this protein in pathogenesis. Here, we show that treatment of B. burgdorferi with human blood induces CspZ production and enhances resistance to complement. By contrast, a cspZ-deficient mutant and a strain that expressed an FH-nonbinding CspZ variant were impaired in their ability to cause bacteraemia and colonize tissues of mice or quail; virulence of these mutants was however restored in complement C3-deficient mice. These novel findings suggest that FH binding to CspZ facilitates B. burgdorferi complement evasion in vivo and promotes systemic infection in vertebrate hosts.

8 February 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
AMAshley L. Marcinkiewicz
Ashley L. Marcinkiewicz
ILIlva Lieknina
Ilva Lieknina
SKSvetlana Kotelovica
Svetlana Kotelovica
XYXiuli Yang
Xiuli Yang
PKPeter Kraiczy
Peter Kraiczy
KTKaspars Tars
Kaspars Tars
The spirochete Borrelia burgdorferi is the causative agent of Lyme disease, the most common tick-borne disease in the US and Europe. No potent human vaccine is currently available. The innate immune complement system is vital to host defense against pathogens, as complement activation on the surface of spirochetes results in bacterial killing. Complement system is inhibited by the complement regulator factor H (FH). To escape killing, B. burgdorferi produces an outer surface protein CspZ that binds FH to inhibit complement activation on the cell surface. Immunization with CspZ alone does not protect mice from infection, which we speculate is because FH-binding cloaks potentially protective epitopes. We modified CspZ by conjugating to virus-like particles (VLP-CspZ) and eliminating FH binding (modified VLP-CspZ) to increase immunogenicity. We observed greater bactericidal antibody titers in mice vaccinated with modified VLP-CspZ: A serum dilution of 1:395 (modified VLP-CspZ) vs 1:143 (VLP-CspZ) yielded 50% borreliacidal activity. Immunizing mice with modified VLP-CspZ cleared spirochete infection, as did passive transfer of elicited antibodies. This work developed a novel Lyme disease vaccine candidate by conjugating CspZ to VLP and eliminating FH-binding ability. Such a strategy of conjugating an antigen to a VLP and eliminating binding to the target ligand can serve as a general model for developing vaccines against other bacterial infectious agents.